Cargando…
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
Major efforts are underway to identify agents that can potentiate effects of immune checkpoint inhibition. Here, we show that ascorbic acid (AA) treatment caused genomewide demethylation and enhanced expression of endogenous retroviral elements in lymphoma cells. AA also increased 5-hydroxymethylcyt...
Autores principales: | Luchtel, Rebecca A., Bhagat, Tushar, Pradhan, Kith, Jacobs, William R., Levine, Mark, Verma, Amit, Shenoy, Niraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983418/ https://www.ncbi.nlm.nih.gov/pubmed/31911474 http://dx.doi.org/10.1073/pnas.1908158117 |
Ejemplares similares
-
ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent
por: Luchtel, Rebecca A., et al.
Publicado: (2022) -
Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
por: Shenoy, Niraj, et al.
Publicado: (2020) -
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer
por: Aggarwal, Ritesh K., et al.
Publicado: (2021) -
Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
por: Shenoy, N, et al.
Publicado: (2017) -
Alterations in the ribosomal machinery in cancer and hematologic disorders
por: Shenoy, Niraj, et al.
Publicado: (2012)